Tetrabromobisphenol A and hexabromocyclododecane alter secretion of IL-1β from human immune cells

References

• Allan SM, Tyrrell PJ, Rothwell NJ. 2005. IL-1 and neuronal injury. Nat Rev Immunol. 5:629–640.
   PubMed Web of Science ®Google Scholar
• Almughamsi HM, Whalen MM. 2015. Hexabromocyclododecane and tetrabromobisphenol a alter secretion of IFNγ from human immune cells. Arch Toxicol. [Epub ahead of print]. doi: 10.1007/s00204-015-1586-6.
   Google Scholar
• Apte RN, Dotan S, Elkabets M, White MR, Reich E, Carmi Y, Song X, Dvozkin T, Krelin Y, Voronov E. 2006. The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor-host interactions. Cancer Metastasis Rev. 25:387–408.
   PubMed Web of Science ®Google Scholar
• Arlt A, Vorndamm J, Müerköster S, Yu H, Schmidt WE, Folsch UR, Schafer H. 2002. Autocrine production of IL–1β confers constitutive NF-κB activity and chemo-resistance in pancreatic carcinoma cell lines. Cancer Res. 62:910–916.
   PubMed Web of Science ®Google Scholar
• Baldassare JJ, Bi Y, Bellone CJ. 1999. The role of p38 mitogen-activated protein kinase in IL-1β transcription. J Immunol. 162:5367–5373.
   PubMed Web of Science ®Google Scholar
• Balkwill F, Coussens LM. 2004. Cancer: An inflammatory link. Nature. 431:405–406.
   PubMed Web of Science ®Google Scholar
• Bar D, Apte RN, Voronov E, Dinarello CA, Cohen S. 2004. Continuous delivery system of IL-1 receptor antagonist reduces angiogenesis and inhibits tumor development. FASEB J. 18:161–163.
   PubMed Web of Science ®Google Scholar
• Birnbaum LS, Staskal DF. 2004. Brominated flame retardants: Cause for concern? Environ Health Perspect. 112:9–17.
   PubMed Web of Science ®Google Scholar
• Brown S, Whalen M. 2015. Tributylin alters secretion of IL-1β from human immune cells. J Appl Toxicol. 35:895–908.
   PubMed Web of Science ®Google Scholar
• Bustnes JO, Yoccoz NG, Bangjord G, Polder A, Skaare JU. 2007. Temporal trends (1986–2004) of organochlorines and brominated flame retardants in tawny owl eggs from northern Europe. Environ Sci Technol. 41:8491–8497.
   PubMed Web of Science ®Google Scholar
• Cariou R, Antignac JP, Zalko D, Berrebi A, Cravedi JP, Maume D, Marchand P, Monteau F, Riu A, Andre F, et al. 2008. Exposure assessment of French women and their newborns to tetrabromobisphenol A: Occurrence measurements in maternal adipose tissue, serum, breast milk, and cord serum. Chemosphere. 73:1036–1041.
   PubMed Web of Science ®Google Scholar
• Cato A, Celada L, Kibakaya EC, Simmons B, Whalen MM. 2014. Brominated flame retardants, tetrabromobisphenol A and hexabromocyclododecane, activate mitogen-activated protein kinases (MAPKs) in human natural killer cells. Cell Biol Toxicol. 30:345–360.
   PubMed Web of Science ®Google Scholar
• Choy EH, Panayi GS. 2001. Cytokine pathways and joint inflammation in rheumatoid arthritis. New Engl J Med. 344:907–916.
   PubMed Web of Science ®Google Scholar
• Church LD, Cook GP, McDermott MF. 2008. Primer: Inflammasomes and IL-1β in inflammatory disorders. Nat Clin Pract Rheumatol. 4:34–42.
   PubMedGoogle Scholar
• Covaci A, Gerecke AC, Law RJ, Voorspoels S, Kohler M, Heeb NV, Allchin LH. 2006. Hexa-bromocyclododecanes (HBCD) in the environment and humans: a review. Environ Sci Technol. 40:3679–3688.
   PubMed Web of Science ®Google Scholar
• Dinarello CA. 1996. Biologic basis for IL-1 in disease. Blood. 87:2095–2147.
   PubMed Web of Science ®Google Scholar
• Dinarello CA. 2009. Immunological and inflammatory functions of the IL-1 family. Annu Rev Immunol. 27:519–550.
   PubMed Web of Science ®Google Scholar
• Dinarello CA. 2010. Why not treat human cancer with IL-1 blockade? Cancer Metastasis Rev. 29:317–329.
   PubMed Web of Science ®Google Scholar
• Elaraj DM, Weinreich DM, Varghese S, Puhlmann M, Hewitt SM, Carroll NM, Feldman ED, Turner EM, Alexander HR. 2006. Role of IL-1 in growth and metastasis of human cancer xenografts. Clin Cancer Res. 12:1088–1096.
   PubMed Web of Science ®Google Scholar
• EFSA (European Food Safety Authority). 2011. Scientific opinion on tetrabromobisphenol A (TBBPA) and its derivatives in food. EFSA J. 9:2477.
   Google Scholar
• Fantuzzi G, Dinarello CA. 1999. IL-18 and IL-1β: two cytokine substrates for ICE (caspase-1). J Clin Immunol. 19:1–11.
   PubMed Web of Science ®Google Scholar
• Glauser DA, Schlegel W. 2007. Sequential actions of ERK1/2 on AP-1 transcription factor allow temporal integration of metabolic signals in pancreatic β-cells. FASEB J. 21:3240–3249.
   PubMed Web of Science ®Google Scholar
• Hinkson NC, Whalen MM. 2009. Hexabromocyclododecane decreases the lytic function and ATP levels of human natural killer cells. J Appl Toxicol. 29:656–661.
   PubMed Web of Science ®Google Scholar
• Hinkson NC, Whalen MM. 2010. Hexabromocyclododecane decreases tumor-cell-binding capacity and cell-surface protein expression of human NK cells. J Appl Toxicol. 30:302–309.
   PubMed Web of Science ®Google Scholar
• HSDB (Hazardous Substances Data Bank). 2001. 2,2′,6,6′-Tetrabromobisphenol A. Bethesda, MD: National Library of Medicine. Available at: http://www.toxnet.nlm.nih.gov/cgi-bin/sis/search [last accessed 2010].
   Google Scholar
• Hurd T, Whalen MM. 2011. Tetrabromobisphenol A decreases cell-surface proteins involved in human natural killer (NK) cell-dependent target cell lysis. J Immunotoxicol. 8:219–227.
   PubMed Web of Science ®Google Scholar
• IPCS/WHO (International Program on Chemical Safety/World Health Organization). 1995. Environmental Health Criteria 172: tetrabromobisphenol A and Derivatives. Geneva: World Health Organization.
   Google Scholar
• Jin L Yuan RQ, Fuchs A, Yao Y, Joseph A, Schwall R, Schnitt SJ, Guida A, Hastings HM, Andres J, et al. 1997. Expression of IL-1β in human breast carcinoma. Cancer. 80:421–434.
   PubMed Web of Science ®Google Scholar
• Kibakaya EC, Stephen K, Whalen MM. 2009. Tetrabromobisphenol A has immunosuppressive effects on human natural killer cells. J Immunotoxicol. 6:285–292.
   PubMed Web of Science ®Google Scholar
• Kim SH, Smith CJ, Eldik LJ. 2004. Importance of MAPK pathways for microglial pro-inflammatory cytokine IL-1β production. Neurobiol Aging. 25:431–439.
   PubMed Web of Science ®Google Scholar
• Law RJ, Kohler M, Heeb NV, Gerecke AC, Schmid P, Voorspoels S, Covaci A, Becher G, Janák K, Thomsen C. 2005. Hexabromocyclododecane challenges scientists and regulators. Environ Sci Technol. 39:281A–287A.
   PubMed Web of Science ®Google Scholar
• Lee CA, Chang JS, Syu SH, Wong TS, Chan JY, Tang YC, Yang ZP, Yang WC, ChenCT, Lu SC, et al. 2015. IL-1β promotes malignant transformation and tumor aggressiveness in oral cancer. J Cell Physiol. 230:875–884.
   Google Scholar
• Legler J, Brouwer A. 2003. Are brominated flame retardants endocrine disruptors? Environ Intl. 29:879–885.
   PubMed Web of Science ®Google Scholar
• Lewis A, Varghese S. 2006. IL-1 and cancer progression: Emerging role of IL-1 receptor antagonist as a novel therapeutic agent in cancer treatment. J Translat Med. 12:1–12.
   Google Scholar
• Lucas K, Hohlfeld R. 1995. Different aspects of cytokines in the immunopathology of multiple sclerosis. Neurology. 45:S4–S5.
   Google Scholar
• Mack AG. 2004. Flame retardants, halogenated. In: Seidel A, Bickford M, editors. Kirk-Othmer Encyclopedia of Chemical Technology. 5th ed. Hoboken (NJ): Wiley and Sons.
   Google Scholar
• Mathias S, Younes A, Kan CC, Orlow I, Joseph C, Kolesnick RN. 1993. Activation of the sphingomyelin signaling pathway in intact EL-4 cells and in a cell-free system by IL-1β. Science. 259:519–522.
   PubMed Web of Science ®Google Scholar
• Meerts IA, van Zanden JJ, Luijks EA, van Leeuwen-Bol I, Marsh G, Jakobsson E, Bergman A, Brouwer A. 2000. Potent competitive interactions of some brominated flame retardants and related compounds with human transthyretin in vitro. Toxicol Sci. 56:95–104.
   PubMed Web of Science ®Google Scholar
• Meyer TP, Zehnter I, Hofmann B, Zaisserer J, Burkhart J, Rapp S, Weinauer F, Schmitz J, Illert WE. 2005. Filter Buffy Coats (FBC): A source of peripheral blood leukocytes recovered from leukocyte depletion filters. J Immunol Meth. 307:150–166.
   PubMed Web of Science ®Google Scholar
• Muerkoster SS Lust J, Arlt A, Häsler R, Witt M, Sebens T, Schreiber S, Fölsch UR, Schäfer H. 2006. Acquired chemo-resistance in pancreatic carcinoma cells: Induced secretion of IL-1β and NO lead to inactivation of caspases. Oncogene. 25:3973–3981.
   PubMed Web of Science ®Google Scholar
• Nagayama J, Takasuga T, Tsuji H. 2001. Contamination levels of brominated flame retardants, dioxins, and organochlorine compounds in the blood of Japanese adults. Human Levels Trends. 2001:218–221.
   Google Scholar
• Nishida E, Gotoh Y. 1993. MAP kinase cascade is essential for diverse signal transduction pathways. Trends Biochem Sci. 18:128–131.
   PubMed Web of Science ®Google Scholar
• Palace V, Park B, Pleskach K, Gemmill B, Tomy G. 2010. Altered thyroxine metabolism in rainbow trout (Oncorhynchus mykiss) exposed to hexabromocyclododecane (HBCD). Chemosphere. 80:165–169.
   PubMed Web of Science ®Google Scholar
• Peterman PH, Orazio CE, Gale RW. 2000. Detection of tetrabromobisphenol A and formation of brominated [13C]-bisphenol A in commercial drinking water stored in reusable poly-carbonate containers. ACS Div Environ Chem. 40:431–433.
   Google Scholar
• Polder A, Venter B, Skaare JU, Bouwman H. 2008. Polybrominated diphenyl ethers and HBCD in bird eggs of South Africa. Chemosphere. 73:148–154.
   PubMed Web of Science ®Google Scholar
• Raingeaud J, Gupta S, Rogers JS, Dickens M, Han J, Ulevitch RJ, Davis RJ. 1995. Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J Biol Chem. 270:7420–7426.
   PubMed Web of Science ®Google Scholar
• Robinson MJ, Cobb MH. 1997. Mitogen-activated protein kinase pathways. Curr Opin Cell Biol. 9:180–186.
   PubMed Web of Science ®Google Scholar
• Saegusa Y, Fujimoto H, Woo GH, Inoue K, Takahashi M, Mitsumori K, Hirose M, Nishikawa A, Shibutani M. 2009. Developmental toxicity of brominated flame retardants tetrabromobisphenol A and 1,2,5,6,9,10-hexabromocyclododecane in rat offspring after maternal exposure from mid-gestation through lactation. Reprod Toxicol. 28:456–467.
   PubMed Web of Science ®Google Scholar
• Schecter A, Szabo DT, Miller J, Gent TL, Malik-Bass N, Petersen M, Paepke O, Colacino JA, Hynan LS, Harris TR, et al. 2012. EHP: Hexabromocyclododecane (HBCD) Stereoisomers in U.S. Food from Dallas, Texas. Environ Health Perspect. 120:1260–1264.
   PubMed Web of Science ®Google Scholar
• Scheibel M, Klein B, Merkle H, Schulz M, Fritsch R, Greten FR, Arkan MC, Schneider G, Schmid RM. 2010. IκBβ is an essential co-activator for LPS-induced IL-1β transcription in vivo. J Exp Med. 207:2621–2630.
   PubMed Web of Science ®Google Scholar
• Simi A, Tsakiri N, Wang P, Rothwell NJ. 2007. IL-1 and inflammatory neurodegeneration. Biochem Soc Trans. 35:1122–1126.
   PubMed Web of Science ®Google Scholar
• Thomsen C, Lundanes E, Becher G. 2002. Brominated flame retardants in archived serum samples from Norway: A study on temporal trends and the role of age. Environ Sci Technol. 36:1414–1418.
   PubMed Web of Science ®Google Scholar
• Thomsen C, Molander P, Daae HL, Janák K, Froshaug M, Liane VH, Thorud S, Becher G, Dybing E. 2007. Occupational exposure to hexabromocyclododecane at an industrial plant. Environ Sci Technol. 41:5210–5216.
   PubMed Web of Science ®Google Scholar
• Thomsen C, Knutsen HK, Liane VH, Frøshaug M, Kvalem HE, Haugen M, Meltzer HM, Alexander J, Becher G. 2008. Consumption of fish from a contaminated lake strongly affects the concentrations of polybrominated diphenyl ethers and hexabromocyclododecane in serum. Mol Nutr Food Res. 52:228–237.
   PubMed Web of Science ®Google Scholar